Viridian Therapeutics, Inc. (VRDN)

NCM – Real Time Price. Currency in USD

23.04

+0.07 (0.30%)

Market open: Aug 12, 2026, 1:05 PM EDT

22.98

+0.01 (0.04%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

06.08.2026

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for autoimmune and rare diseases, today reported recent business highlights and financial results for the second quarter ended June 30, 2026. “We are very encouraged by the early indications from our recent launch of Lumvoa as we start a new chapter for Viridian as a commercial-stage company,” said Steve.

Videos

No Data

There is no data to display

Press releases

06.08.2026

Viridian Therapeutics, Inc. (VRDN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Viridian Therapeutics, Inc. (VRDN)

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Videos

No Data

Press releases

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Videos

No Data

Press releases

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Search stocks

Viridian Therapeutics, Inc. (VRDN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Viridian Therapeutics, Inc. (VRDN)

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Videos

No Data

Press releases

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Videos

No Data

Press releases

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results